Shola Adewale

Dir, Clinical Development Strategy Lead @Boehringer Ingelheim

Florissant, MO, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2024 — Present

Dir, Clinical Development Strategy Lead @Boehringer Ingelheim

View department →

EDUCATION

1998 — 2004

Saint Louis University

PhD, Pharmacological and Physiological Science

2012 — 2014

Saint Joseph's University - Erivan K. Haub School of Business

Master of Business Administration (M.B.A.)

SKILLS

GastroenterologyHematologyCardiologyClinical ResearchOncologyUrologyMedicineMedical AffairsNeurologyMedical WritingRheumatologyEndocrinologyImmunologyPharmaceutical IndustryDiabetesManaged CareClinical DevelopmentTherapeutic AreasInfectious DiseasesClinical Trials

ABOUT SHOLA ADEWALE

Leader in Medical Affairs with in-depth therapeutic expertise in areas including urology, anesthesiology, gastroenterology, pain management, neurology, oncology (prostate and bladder), hepatology, addiction, ultra-rare diseases and gene therapy (AAV platform).Experienced in rare diseases Central Precocious Puberty and Lennox-Gastaut Syndrome, hepatic encephalopathy, Batten disease, mucopolysaccharidoses disease (MPS) and Niemann-Pick disease (NPC). Experienced leader in development, management, retainment, and support of field based MSL teams.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Shola Adewale — Dir, Clinical Development Strategy Lead at Boehringer Ingelheim in Florissant, MO, US | Unifers